Phibro Animal Health (NASDAQ:PAHC) Price Target Raised to $25.00

Phibro Animal Health (NASDAQ:PAHC) had its target price boosted by Morgan Stanley from $20.00 to $25.00 in a research report report published on Tuesday morning,Benzinga reports. Morgan Stanley currently has an equal weight rating on the stock.

A number of other research analysts have also issued reports on the company. Bank of America increased their target price on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research report on Friday, August 30th. Barclays boosted their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 12th. StockNews.com lowered shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Friday, December 6th. Finally, JPMorgan Chase & Co. started coverage on Phibro Animal Health in a research note on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $20.50.

Phibro Animal Health Stock Performance

NASDAQ PAHC opened at $21.81 on Tuesday. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81. Phibro Animal Health has a twelve month low of $10.03 and a twelve month high of $25.98. The stock has a 50-day moving average of $23.61 and a 200 day moving average of $20.66. The stock has a market capitalization of $883.37 million, a price-to-earnings ratio of 50.72, a PEG ratio of 0.58 and a beta of 0.51.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.20%. The ex-dividend date of this dividend was Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio is currently 111.63%.

Hedge Funds Weigh In On Phibro Animal Health

Institutional investors have recently added to or reduced their stakes in the stock. Brandes Investment Partners LP grew its holdings in Phibro Animal Health by 1.2% in the 2nd quarter. Brandes Investment Partners LP now owns 2,405,629 shares of the company’s stock valued at $40,521,000 after buying an additional 29,071 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Phibro Animal Health by 5.7% in the second quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock valued at $13,005,000 after purchasing an additional 42,086 shares during the period. Acadian Asset Management LLC increased its position in Phibro Animal Health by 6.3% during the second quarter. Acadian Asset Management LLC now owns 717,506 shares of the company’s stock worth $12,027,000 after purchasing an additional 42,299 shares during the last quarter. Dana Investment Advisors Inc. raised its stake in Phibro Animal Health by 17.2% during the second quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company’s stock worth $8,619,000 after purchasing an additional 75,546 shares during the period. Finally, Geode Capital Management LLC boosted its holdings in Phibro Animal Health by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock valued at $11,430,000 after purchasing an additional 27,201 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.